Quetiapine Discontinuation After Missing 2 Days
After missing 2 days of quetiapine 50mg, a person with bipolar disorder may experience withdrawal symptoms including insomnia, nausea, vomiting, anxiety, irritability, dizziness, and headache, though at this low dose the symptoms are likely to be mild and resolve within a week.
Expected Discontinuation Symptoms
The FDA label for Seroquel explicitly warns about discontinuation syndrome after abrupt cessation 1. In clinical trials of quetiapine XR, 12.1% of patients experienced one or more discontinuation symptoms after abrupt cessation compared to 6.7% on placebo. The specific symptoms documented include:
- Insomnia (most common psychiatric symptom)
- Nausea and vomiting (most common gastrointestinal symptoms)
- Headache
- Dizziness
- Irritability
- Anxiety
- Diarrhea
Importantly, no individual symptom exceeded 5.3% incidence and symptoms typically resolved within 1 week post-discontinuation 1.
Dose-Dependent Considerations
At 50mg daily, this is a relatively low dose of quetiapine. A recent systematic review found that quetiapine has one of the higher risks for withdrawal symptoms among antipsychotics (ROR 4.24) 2, but the severity correlates with dose and duration of treatment. The comprehensive systematic review identified somatic symptoms including nausea, vomiting, agitation, restlessness, diaphoresis, tachycardia, hypertension, and sleep disturbance 3.
Three case reports in the systematic review also documented withdrawal dyskinesia with choreiform movements, though this appears rare and typically occurs with higher doses and longer treatment duration 3.
Clinical Context for 2-Day Gap
A pharmacokinetic study specifically examined missed doses of quetiapine and found that missing 1-2 consecutive doses significantly decreased trough concentrations but levels rapidly returned to baseline when regular dosing resumed 4. The study showed that while BPRS scores were impacted by missed doses, the clinical effect rapidly normalized with resumption of the regular dose 4.
Practical Management
Given the 2-day gap at 50mg:
- Most likely scenario: Mild insomnia and possible anxiety/irritability
- Less likely but possible: Nausea, headache, dizziness
- Unlikely at this dose/duration: Severe withdrawal symptoms or dyskinesia
The patient should resume their regular 50mg dose immediately rather than attempting to "catch up" with extra doses. The FDA label explicitly states that gradual withdrawal is advised to minimize discontinuation symptoms 1, but after only a 2-day interruption at this low dose, simply resuming the regular schedule is appropriate.
Important Caveat
Do not confuse withdrawal symptoms with relapse of bipolar symptoms. If the patient experiences mood destabilization (emerging mania or depression), this represents loss of therapeutic effect rather than withdrawal syndrome. The quetiapine was being used for mood stabilization in bipolar disorder 5, so the 2-day gap may also allow underlying mood symptoms to re-emerge, which is a separate concern from withdrawal symptoms.